These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 37265504)

  • 21. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
    Kang Y; Pan W; Cai Y
    Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucin glycans and their degradation by gut microbiota.
    Yamaguchi M; Yamamoto K
    Glycoconj J; 2023 Aug; 40(4):493-512. PubMed ID: 37318672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut bacteria, host immunity, and colorectal cancer: From pathogenesis to therapy.
    Li Y; Peng J; Meng X
    Eur J Immunol; 2024 Oct; 54(10):e2451022. PubMed ID: 38980275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
    Wong SH; Yu J
    Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):690-704. PubMed ID: 31554963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbiota and beneficial metabolites in colorectal cancer.
    González A; Fullaondo A; Odriozola I; Odriozola A
    Adv Genet; 2024; 112():367-409. PubMed ID: 39396841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 27. Interplay between Dietary Polyphenols and Oral and Gut Microbiota in the Development of Colorectal Cancer.
    Cueva C; Silva M; Pinillos I; Bartolomé B; Moreno-Arribas MV
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32120799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-omic profiling reveals associations between the gut mucosal microbiome, the metabolome, and host DNA methylation associated gene expression in patients with colorectal cancer.
    Wang Q; Ye J; Fang D; Lv L; Wu W; Shi D; Li Y; Yang L; Bian X; Wu J; Jiang X; Wang K; Wang Q; Hodson MP; Thibaut LM; Ho JWK; Giannoulatou E; Li L
    BMC Microbiol; 2020 Apr; 20(Suppl 1):83. PubMed ID: 32321427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exercise-induced changes to the human gut microbiota and implications for colorectal cancer: a narrative review.
    Boytar AN; Nitert MD; Morrision M; Skinner TL; Jenkins DG
    J Physiol; 2022 Dec; 600(24):5189-5201. PubMed ID: 36369926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Inhibitory Effect of Gut Microbiota and Its Metabolites on Colorectal Cancer.
    Chen C; Li H
    J Microbiol Biotechnol; 2020 Nov; 30(11):1607-1613. PubMed ID: 32522960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyzing the Secretome of Gut Microbiota as the Next Strategy For Early Detection of Colorectal Cancer.
    Megat Mohd Azlan PI; Chin SF; Low TY; Neoh HM; Jamal R
    Proteomics; 2019 May; 19(10):e1800176. PubMed ID: 30557447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for the treatment of colorectal cancer caused by gut microbiota.
    de Souza JB; Brelaz-de-Castro MCA; Cavalcanti IMF
    Life Sci; 2022 Feb; 290():120202. PubMed ID: 34896161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of the gut microbiome in multistep colorectal carcinogenesis.
    Mizutani S; Yamada T; Yachida S
    Cancer Sci; 2020 Mar; 111(3):766-773. PubMed ID: 31910311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gastrointestinal microbiota and colorectal cancer.
    Keku TO; Dulal S; Deveaux A; Jovov B; Han X
    Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G351-63. PubMed ID: 25540232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota in colorectal cancer development and therapy.
    Wong CC; Yu J
    Nat Rev Clin Oncol; 2023 Jul; 20(7):429-452. PubMed ID: 37169888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer.
    Song M; Chan AT; Sun J
    Gastroenterology; 2020 Jan; 158(2):322-340. PubMed ID: 31586566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colon mucus in colorectal neoplasia and beyond.
    Loktionov A
    World J Gastroenterol; 2022 Aug; 28(32):4475-4492. PubMed ID: 36157924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The gut barrier as a gatekeeper in colorectal cancer treatment.
    Hajjar R; Richard C; Santos MM
    Oncotarget; 2024 Aug; 15():562-572. PubMed ID: 39145528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered intestinal microbiota associated with colorectal cancer.
    Zhang H; Chang Y; Zheng Q; Zhang R; Hu C; Jia W
    Front Med; 2019 Aug; 13(4):461-470. PubMed ID: 31250341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.